SULFAZINK FORT 30 MG/5 ML SYRUP – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for SULFAZINK FORT 30 MG/5 ML SYRUP, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: SULFAZINK FORT 30 MG/5 ML SYRUP

Manufacturer: Hakay Pharmaceutical Marketing Industry and Trade Ltd. Co.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

CINKO 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

SULFAZINK FORT 30 MG/5 ML SYRUP is formulated with CINKO, a clinically established agent in medical practice.

  • Mechanism of Action: CINKO acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to CINKO therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name SULFAZINK FORT 30 MG/5 ML SYRUP
Barcode (GTIN) 8699705570059
Generic Name CINKO
License Holder Hakay Pharmaceutical Marketing Industry and Trade Ltd. Co.
Pharmacy Retail Price 200.11 TL
⚠️ Clinical Safety Warning

Do not administer SULFAZINK FORT 30 MG/5 ML SYRUP if the patient has a known hypersensitivity or allergy to CINKO. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via Hakay Pharmaceutical Marketing Industry and Trade Ltd. Co..

Leave a Comment